Design and rationale of a randomized clinical trial assessing the effect of inclisiran on atherosclerotic plaque in individuals without previous cardiovascular event and without flow- limiting lesions identified in an in-hospital screening – The VICTORION-PLAQUE primary prevention trial
Related Posts
Song Z, Sui F, Huang X, Liu MB, Gao W, Weiss JN, Qu Z. Population Modeling Approach for Human Cardiac Arrhythmia Risk Prediction. Circ Arrhythm[...]
Grant JK, Jha K, Marrero N, Razavi AC, Boakye E, Anchouche K, Dzaye O, Budoff MJ, Shah S, Czarny MJ, Rotter JI, Guo X, Yao[...]
Goel NE, Shivkumar K. Amara Yad Image: Sectional View of the Left Ventricular Outflow Tract Viewed From the Superior Direction. J Am Coll Cardiol. 2026[...]